[Complications in treatment with proteolytic enzymes (literature review)].
D000707:Anaphylaxis / Q000139:chemically induced; D002056:Burns / Q000188:drug therapy; D002918:Chymotrypsin / Q000008:administration & dosage / Q000009:adverse effects; D003851:Deoxyribonucleases / Q000008:administration & dosage / Q000009:adverse effects; D003875:Drug Eruptions; D004653:Empyema / Q000188:drug therapy; D006491:Hemothorax / Q000188:drug therapy; D006801:Humans; D008169:Lung Abscess / Q000188:drug therapy; D010019:Osteomyelitis / Q000188:drug therapy; D010447:Peptide Hydrolases / Q000008:administration & dosage / Q000009:adverse effects*; D011711:Pyoderma / Q000188:drug therapy; D013299:Streptodornase and Streptokinase / Q000008:administration & dosage / Q000009:adverse effects; D014357:Trypsin / Q000008:administration & dosage / Q000009:adverse effects
D013299:Streptodornase and Streptokinase; D003851:Deoxyribonucleases; D010447:Peptide Hydrolases; D002918:Chymotrypsin; D014357:Trypsin
Oslozhneniia pri lechenii proteoliticheskimi fermentami (obzor literatury.